IPOX Schuster IPOX Schuster

The IPOX® Update 1/5/24

In 2024, the global IPO landscape is flourishing with major filings across various sectors. Amer Sports aims for a $10 billion US IPO, while Germany anticipates a surge in listings. Telix Pharmaceuticals eyes a Nasdaq IPO, Sodexo prepares to spin off Pluxee, and BrightSpring Health seeks a $1 billion IPO. Dubai establishes Parkin for its IPO, Smith Douglas Homes plans a real estate IPO, South Korea's market is vibrant with nine upcoming IPOs, and the biotech sector sees a surge in M&A and IPOs, forecasting a bright 2024.

Read More
IPOX Schuster IPOX Schuster

The IPOX® Update 12/20/23

Saudi Arabian airline Flynas plans a 2024 IPO with Goldman Sachs and Morgan Stanley's assistance, as part of Saudi Arabia's economic diversification efforts. This follows the successful IPO of SAL Saudi Logistics Services. Additionally, the Lebara telecommunications group is considering an IPO amid customer growth. Europe's ESMA is working to boost the region's IPO appeal. ServiceTitan is preparing for a 2024 IPO, and Schott Pharma's stock rose post-SDAX inclusion. Fractyl Health files for a $100 million IPO for diabetes and obesity treatments.

Read More
IPOX Schuster IPOX Schuster

The IPOX® Update 12/13/23

Private equity firm General Atlantic, Walgreens Boots Alliance, and Apex Fintech Solutions plan IPOs, while Carlyle Group explores options for Acrotec, and Pleo appoints a new CFO signaling an upcoming IPO. In the MENA region, MBC Group and PureHealth's IPOs attracted massive demand, highlighting strong investor interest despite a challenging global IPO market.

Read More
IPOX Schuster IPOX Schuster

The IPOX® Update 12/11/23

Shein considers a UK listing after confidential US filing, with its valuation adjusted to $66 billion. ZKH Group aims to raise $66 million in a US IPO. Marex Group shifts its IPO focus from London to New York. Mumbai's stock market sets IPO records. Hong Kong brokers seek regulatory reform for small-cap market. IPOX® holding Doordash joins the Nasdaq 100 Index.

Read More
IPOX Schuster IPOX Schuster

The IPOX® Update 12/6/23

The global IPO market is showing signs of recovery, with UBS Group AG forecasting a rebound. Mumbai leads the 2023 IPO count, surpassing major Chinese financial centers. Ola Electric, ByteDance, Southwest Gas, Capital A Berhad, and Nio in focus. Positive news for IPOX® Europe members Pharvaris and Schott Pharma.

Read More
IPOX Schuster IPOX Schuster

The IPOX® Update 12/4/23

Uber's stock surged 5% with its S&P 500 inclusion, boosting the IPOX® 100 U.S. Index. Aspen, backed by Apollo Global Management, plans a $4 billion IPO in New York. Singapore's first SPAC merger features VTAC and Taiwanese app 17LIVE Inc. UK's Waterstones, under Elliott Management, is contemplating an IPO. Lastly, Phoenix Group is set for an IPO in Abu Dhabi, marking a milestone in Middle East's crypto and blockchain sector.

Read More
IPOX Schuster IPOX Schuster

The IPOX® Update 12/1/23

The U.S. IPO market is rebounding, with indices like IPOX® SPAC and IPOX® Composite US showing growth, signaling a positive shift in investor sentiment. Panera Bread plans a 2024 IPO under new leadership, while HPS Investment Partners targets an IPO with an $8 billion valuation. PureHealth Holding aims to raise $1 billion in an Abu Dhabi IPO. Xtalpi, an AI drug discovery firm, files for a Hong Kong IPO. Zeekr delays its U.S. IPO due to market volatility.

Read More
IPOX Schuster IPOX Schuster

The IPOX® Update 11/29/23

Lineage Logistics LLC aims for a $30 billion valuation in its 2024 U.S. IPO, while UL Solutions Inc. targets a $5 billion valuation. ZKH Group Ltd. seeks to raise up to $150 million in a U.S. IPO. Air Astana plans a dual IPO in London and Kazakhstan, valued at around $1 billion. Hong Kong is focusing on the Middle East and Southeast Asia to boost IPO activity.

Read More
IPOX Schuster IPOX Schuster

The IPOX® Update 11/28/23

The 2024 IPO landscape features diverse companies including Reddit, Skims, Zeekr, Rubrik, Waystar, Shein, and Lotus Technology, each targeting significant valuations in their respective sectors. 3M is spinning off its healthcare segment as 'Solventum', and Cellulant Ltd. has reconsidered its IPO plans amid funding shifts.

Read More